Implement and utilize various mechanisms, including legal measures, policies, administration, and capacity-building that are effective at all levels and across all appropriate sectors, to ensure the fair and equitable sharing of benefits arising from the utilization of genetic resources and from digital sequence information on genetic resources, as well as traditional knowledge associated with genetic resources. Facilitate appropriate access to genetic resources and increase shared benefits in accordance with international access and benefit-sharing instruments. Target value is set for 2027 as follows:
1. Establish mechanisms and regulations for access and benefit-sharing of genetic resources that all responsible agencies adopt as the country's standard. 
2. All responsible agencies enforce the mechanisms and regulations for access and benefit-sharing.
3. Users, possessors, and relevant stakeholders have the capacity for fair and equitable access and benefit-sharing.
4. Increased benefits, both in monetary forms generating income and non-monetary forms (knowledge, information, and cooperation), from the use of the country's genetic resources
5. All responsible agencies have established biosafety measures, and 50% of educational institutions with institutional biosafety committees have established biosafety mechanisms and guidelines.
 

There are three measures to achieve this national target.
1. Promote and encourage the concrete implementation of mechanism for access and benefit-sharing of genetic resources.
2. Build capacity, knowledge, and understanding in managing access and benefit-sharing among all sectors and at all levels.
3. Strengthen biosafety measures and capabilities to support sustainable use and conservation of biodiversity.
 

They are reflected in measures and actions taken for this target as attached.  Target 7 ABS_measures and actions.docx 

The sharing of benefits arising from the utilization of genetic resources and associated traditional knowledge is one of the three objectives of the Convention on Biological Diversity and a key pillar for successful implementation. It establishes equity between providers/holders and users/requestors of biodiversity, with the dual objective of creating incentives for conservation and sustainable use of biodiversity, while facilitating access and sharing. Additionally, it encourages the equitable sharing of benefits arising from the use of knowledge, innovations, and practices with local communities. 
Enhance capabilities and implement biosafety measures, as well as measures for managing biotechnology and benefit distribution. Biosafety measures are essential in ensuring that genetically modified organisms resulting from biotechnology are managed and used with necessary safety precautions. The use of genetically modified organisms presents opportunities for economic and social development, however their use and release require regulations, management, and control of associated potential risks.
Support research using biotechnology for the country. Providing genetic resources for such research will allow researchers and academics to study conveniently and transparently. Moreover, equal access has positive effects and creates benefits from the use of biotechnology from genetic resources without obstacles and in a timely manner. Additionally, it will help in gaining benefits from advancements in biotechnology that use genetic resources as a basis, ultimately resulting in incentives for biodiversity conservation.
To accomplish this, it needs to be considered in carrying out following actions:
1. Legal, policy and administrative measures—The country needs to employ legal, policy, and administrative measures to implement access and benefit-sharing (ABS) of genetic resources. This includes establishing institutional structures such as agencies for notification and authorization, among others. These are necessary to follow the steps required to comply with international treaty obligations at the national level and to have a fully functional system and mechanism. For example, administrative measures for issuing permits or the operation of import-export checkpoints in accordance with these measures will help increase the possibility of managing access and benefit-sharing fairly and equitably, and facilitate appropriate access to genetic resources.
2. Capacity-building measures—there is a need to build knowledge and understanding of access and benefit-sharing (ABS) management across all sectors and levels. This includes developing capacity for managing genetic resources, digital sequence information (DSI), and associated traditional knowledge.
 

Civil Society Organizations (CSO): CSO work in Thailand
Private Sectors: Industries related to biotechnology, including pharmaceutical, food and beverage, agricultural, forestry, aquaculture and livestock sectors, as well as small and medium enterprises (SMEs) and community enterprises
Academic Institutes: Universities
 

Capacity-building and development, Access to and transfer of technologies, Development of and access to innovation, Technical and scientific cooperation, establish network and partnership, matching fund